Loading...
Mixed Asset Passive

KBSTAR Healthcare Fixed Income Balanced (253290)

Update : 2023.03.24

NAV

10,822KRW

-0.52하락 (-%)

Market Price per share (KRW)

10,830KRW

+35상승 (0.32%)

※ t-1 last price

trading volume

1,846shares

AUM

KRW 12.9billion

KBSTAR Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2023.03.24
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB KBSTAR HealthCare FixedIncome Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 12,986,800,980
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 10,830
※ t-1 last price
10,822 1,846
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency 다운로드 버튼
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB KBSTAR HealthCare FixedIncome Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
12,986,800,980 하나은행
Market Price per share (KRW) iNAV per share (KRW)
10,830
※ t-1 last price
10,822
Trading Volume (shares)
1,846
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2023-03-24
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB01875-2412(21-10) 26.28
2 KTB03125-2506(22-4) 19.23
3 KTB03125-2709(22-8) 15.24
4 KBSTAR HealthCare 10.18
5 F 202306 9.89
6 원화예금 8.92
7 Celltrion Healthcare 2.03
8 HLB 1.96
9 SAMSUNG BIOLOGICS 1.90
10 Celltrion 1.78

proportion by sectors

*The proportion of investment stocks

Update : 2023.03.24
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2022-06-09 2022-06-13 16
2022-12-08 2022-12-12 91
2021-06-09 2021-06-11 10
2021-12-09 2021-12-13 11
2020-06-09 2020-06-11 10

Performance

performance

excel download

Update : 2023-03-24

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV 1.51 0.97 3.90 -4.59 9.21 1.76 9.54
Benchmark Index 1.75 1.29 4.64 -3.96 10.31 2.20 12.85
Outperformance -0.24 -0.33 -0.74 -0.63 -1.1 -0.45 -3.32

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2023.03.24 10,830 0.324상승 10,822.85 -0.435하락
2023.03.23 10,795 -0.644하락 10,870.15 0.004상승
2023.03.22 10,865 -0.183하락 10,869.65 -0.165하락
2023.03.21 10,885 0.184상승 10,887.67 0.439상승
2023.03.20 10,865 0.462상승 10,840.02 0.004상승
2023.03.17 10,815 1.169상승 10,700.72 0.064상승
2023.03.16 10,690 0.328상승 10,693.79 0.322상승
2023.03.15 10,655 0.046상승 10,659.44 -0.887하락
2023.03.14 10,650 -0.745하락 10,754.91 0.432상승
2023.03.13 10,730 0.374상승 10,708.63 0.005상승
2023.03.10 10,690 -0.279하락 10,762.72 0.564상승
2023.03.09 10,720 0.186상승 10,702.32 -0.635하락
2023.03.08 10,700 -0.465하락 10,770.74 0.970상승
2023.03.07 10,750 0.749상승 10,667.21 0.068상승
2023.03.06 10,670 0.234상승 10,659.87 0.005상승
2023.03.03 10,645 0.614상승 10,575.74 -0.158하락
2023.03.02 10,580 -0.235하락 10,592.48 0.005상승
2023.02.28 10,605 - 10,583.45 -0.738하락
2023.02.27 10,605 -0.609하락 10,662.2 0.005상승

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value
Weight(%) Market price (KRW)
1 KTB01875-2412(21-10) KR103501GBC2 583,333,333 26.28 572,779,083
2 KTB03125-2506(22-4) KR103501GC66 416,666,667 19.23 419,145,833
3 KTB03125-2709(22-8) KR103501GC90 333,333,333 15.24 332,142,999
4 KBSTAR HealthCare KR7253280002 21,141 10.18 221,874,795
5 F 202306 KR4165T60001 2.05 9.89 215,537,000
6 원화예금 KRD010010001 194,396,147 8.92 194,396,147
7 Celltrion Healthcare KR7091990002 687 2.03 44,242,800
8 HLB KR7028300002 1,181 1.96 42,752,200
9 SAMSUNG BIOLOGICS KR7207940008 52 1.9 41,496,000
10 Celltrion KR7068270008 251 1.78 38,779,500
11 Yuhan KR7000100008 584 1.36 29,608,800
12 HanmiPharm KR7128940004 81 0.96 20,938,500
13 HUMASIS KR7205470008 1,289 0.91 19,811,930
14 Celltrionph KR7068760008 199 0.85 18,546,800
15 SKBP KR7326030004 298 0.84 18,386,600
16 SKBS KR7302440003 232 0.75 16,263,200
17 MedyTox KR7086900008 56 0.54 11,816,000
18 Hanmi Science KR7008930000 297 0.52 11,434,500
19 BIONEER KR7064550007 242 0.47 10,333,400
20 SEEGENE KR7096530001 397 0.45 9,905,150
21 SCD KR7000250001 148 0.4 8,732,000
22 DENTIUM KR7145720009 72 0.39 8,510,400
23 SD Biosensor KR7137310009 396 0.38 8,375,400
24 ST Pharm KR7237690003 109 0.37 8,011,500
25 GC Corp KR7006280002 60 0.33 7,086,000
26 HANALL BIOPHARMA KR7009420001 385 0.31 6,795,250
27 ShinpoongPharm KR7019170000 361 0.29 6,328,330
28 Lutronic KR7085370005 227 0.25 5,448,000
29 CHA Biotech KR7085660009 434 0.25 5,385,940
30 HK inno.N KR7195940002 158 0.24 5,300,900
31 DAEWOONG PHARM KR7069620003 49 0.24 5,159,700
32 PharmaResearch KR7214450009 66 0.21 4,606,800
33 Jeisys Medical KR7287410005 542 0.21 4,590,740
34 ILDONG PHARM KR7249420001 177 0.18 3,858,600
35 CLASSYS KR7214150005 188 0.16 3,556,960
36 GC CELL KR7144510005 87 0.16 3,510,450
37 YUNGJIN PHARM KR7003520004 981 0.13 2,800,755
38 Boryung KR7003850005 322 0.12 2,604,980
39 KUP KR7033270000 98 0.09 2,004,100
40 KUKJEON KR7307750000 208 0.05 1,127,360
41 KOREA PHARMA KR7032300006 37 0.03 738,890
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.